Unibest
← Back to patent-cliff list

CAS 1448870-70-9

2-bromo-5-(((5-chloro-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)amino)(4-chlorophenyl)methyl)-1-isopropyl-1H-imidazole-4-carboxylic acid

Codes: HDM-201-010

Application context (from source-drug indications)

SarcomaSiremadlinHaematological malignancySiremadlinHepatic function declineSiremadlinAcute myeloid leukaemiaSiremadlinColorectal cancerSiremadlinMetastatic cancerSiremadlin

Source drugs (routes using this intermediate)

DrugTierExpiry
SiremadlinTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.